0000899243-15-008648.txt : 20151120
0000899243-15-008648.hdr.sgml : 20151120
20151120200051
ACCESSION NUMBER: 0000899243-15-008648
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151119
FILED AS OF DATE: 20151120
DATE AS OF CHANGE: 20151120
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Juno Therapeutics, Inc.
CENTRAL INDEX KEY: 0001594864
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 463656275
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 307 WESTLAKE AVENUE NORTH, SUITE 300
CITY: SEATTLE
STATE: WA
ZIP: 98109
BUSINESS PHONE: 2066960703
MAIL ADDRESS:
STREET 1: 307 WESTLAKE AVENUE NORTH, SUITE 300
CITY: SEATTLE
STATE: WA
ZIP: 98109
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cassidy Bernard J
CENTRAL INDEX KEY: 0001398322
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36781
FILM NUMBER: 151248135
MAIL ADDRESS:
STREET 1: C/O TUMBLEWEED COMMUNICATIONS CORP
STREET 2: 700 SAGINAW DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-11-19
0
0001594864
Juno Therapeutics, Inc.
JUNO
0001398322
Cassidy Bernard J
307 WESTLAKE AVENUE NORTH, SUITE 300
SEATTLE
WA
98109
0
1
0
0
General Counsel and Secretary
Common Stock
2015-11-19
4
S
0
2895
52.9067
D
71505
D
Common Stock
2015-11-19
4
S
0
305
53.5574
D
71200
D
Common Stock
26869
I
By Morgan Stanley Smith Barney LLC as Custodian for Bernard Cassidy IRA
This transaction was executed in multiple trades at prices ranging from $52.478 to $53.43. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $53.49 to $53.80. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 23, 2014, in which the shares were sold through a trust for the sole benefit of the reporting person and his spouse.
/s/ Zachary Hale, attorney-in-fact
2015-11-20